Correlation Between ExpreS2ion Biotech and Biovica International
Specify exactly 2 symbols:
By analyzing existing cross correlation between ExpreS2ion Biotech Holding and Biovica International AB, you can compare the effects of market volatilities on ExpreS2ion Biotech and Biovica International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ExpreS2ion Biotech with a short position of Biovica International. Check out your portfolio center. Please also check ongoing floating volatility patterns of ExpreS2ion Biotech and Biovica International.
Diversification Opportunities for ExpreS2ion Biotech and Biovica International
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between ExpreS2ion and Biovica is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding ExpreS2ion Biotech Holding and Biovica International AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biovica International and ExpreS2ion Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ExpreS2ion Biotech Holding are associated (or correlated) with Biovica International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biovica International has no effect on the direction of ExpreS2ion Biotech i.e., ExpreS2ion Biotech and Biovica International go up and down completely randomly.
Pair Corralation between ExpreS2ion Biotech and Biovica International
Assuming the 90 days trading horizon ExpreS2ion Biotech Holding is expected to generate 0.96 times more return on investment than Biovica International. However, ExpreS2ion Biotech Holding is 1.04 times less risky than Biovica International. It trades about 0.1 of its potential returns per unit of risk. Biovica International AB is currently generating about -0.04 per unit of risk. If you would invest 1,996 in ExpreS2ion Biotech Holding on December 1, 2024 and sell it today you would earn a total of 644.00 from holding ExpreS2ion Biotech Holding or generate 32.26% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
ExpreS2ion Biotech Holding vs. Biovica International AB
Performance |
Timeline |
ExpreS2ion Biotech |
Biovica International |
ExpreS2ion Biotech and Biovica International Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ExpreS2ion Biotech and Biovica International
The main advantage of trading using opposite ExpreS2ion Biotech and Biovica International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ExpreS2ion Biotech position performs unexpectedly, Biovica International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biovica International will offset losses from the drop in Biovica International's long position.ExpreS2ion Biotech vs. Bavarian Nordic | ExpreS2ion Biotech vs. BioPorto | ExpreS2ion Biotech vs. Zaptec AS | ExpreS2ion Biotech vs. cBrain AS |
Biovica International vs. Hansa Biopharma AB | Biovica International vs. Xbrane Biopharma AB | Biovica International vs. BioArctic AB | Biovica International vs. Cantargia AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |